DEA Schedule I researcher registration: what it involves and how to get it

Last reviewed: August 2026 · Psychedelic law changes quickly — verify current status before relying on this page.

Who this is for: Researchers and institutions planning to conduct studies that require possessing or handling a Schedule I controlled substance, including psilocybin, MDMA, DMT, and mescaline.

The short answer

A researcher who needs to possess, handle, or administer a Schedule I controlled substance must register with the DEA as a Schedule I researcher before doing so. This registration is separate from the FDA’s IND authorization and must be in place independently. The application requires a description of the research, the substance and quantities needed, the security of the storage and handling site, and an institutional endorsement. The DEA reviews each application and can impose conditions. Registration is site-specific and substance-specific, so a researcher who moves locations or adds a substance needs a new or amended registration. The process takes time and should be started well before the planned study date.

Why a separate DEA registration is required

The Controlled Substances Act makes possessing a Schedule I substance illegal unless the DEA has authorized it. An FDA IND addresses whether the study may proceed clinically; the DEA registration addresses whether the researcher may lawfully hold the substance. The two authorizations come from different agencies, address different questions, and must be secured separately. What researchers and institutions need to know before running a psychedelic study covers how they fit together. A researcher who has an IND but no DEA registration may not legally possess the study drug.

Who must register

Every researcher who will personally possess or handle a Schedule I substance needs their own DEA registration, unless they are working under a practitioner who holds the registration and the handling is within the scope of that practitioner’s registration. In practice, the principal investigator on a psychedelic study obtains the registration, and the institution’s compliance office often has to endorse the application. Some institutions hold a Schedule I research registration at the institution level and extend it to covered researchers; those arrangements vary by institution.

What the application requires

The DEA application for Schedule I researcher registration, filed on DEA Form 225, asks for the researcher’s identity and institutional affiliation, the specific Schedule I substance or substances the registration will cover, the quantities the researcher expects to need, a description of the research purpose and protocol, and information about the physical security of the location where the substance will be stored and handled. The DEA requires that Schedule I substances be stored in a securely locked, substantially constructed cabinet, and it may inspect the facility. An institutional letter supporting the application and confirming the security arrangements is typically required.

The security requirements

Storage and handling of Schedule I substances must meet the DEA’s physical security standards. For researchers, this generally means a safe or steel cabinet with a combination lock or keyed lock, bolted to the floor or wall, in a location with controlled access. Electronic alarm systems are common, and the DEA may inspect the storage site before approving or renewing a registration. A new lab or facility that has not previously held Schedule I substances will need to set up and document the security infrastructure as part of the registration process.

How long the process takes

The DEA does not commit to a fixed review period for Schedule I researcher registrations, and processing times vary. A straightforward application from an established institution with existing security infrastructure typically takes several months. An application from a new site, or one with questions the DEA wants to explore, can take longer. A researcher who assumes the registration will arrive in time for a planned study start date runs the risk of a delay that halts enrollment. Starting the registration process early, ideally six months or more before the study is expected to begin, is the standard practice.

Registration is site-specific and substance-specific

A DEA researcher registration covers the named researcher at the named location for the named substance or substances. Moving to a new lab, adding a new substance, or substantially changing the protocol can require an amendment or a new registration. A researcher who conducts studies at multiple institutions may need registrations at each site. The quantities authorized are also part of the registration, and receiving more than authorized requires an amendment.

Recordkeeping and reporting obligations

A registered researcher must keep records of the receipt, use, and disposal of the Schedule I substance, accurate enough to account for every gram. These records are subject to DEA inspection. Theft or loss of the substance must be reported to the DEA promptly, and disposal of unused material must follow the DEA’s procedures rather than ordinary waste. The recordkeeping obligations last for two years from the date of each record.

Renewal

DEA registrations must be renewed annually. The renewal is a continued authorization, not a new application, but it requires the researcher to confirm that the information in the registration remains accurate and to pay the renewal fee. A lapse in registration means the researcher may not lawfully possess the substance until the renewal is in place, which can interrupt an ongoing study.

When public information may be enough

The DEA’s registration requirements, the Form 225, and the security standards are all public, and an institution’s compliance office often has experience with the process. A researcher can read the requirements and understand what the application needs before contacting the DEA. Institutions that have registered before can share their experience and their security documentation.

When you should speak with a lawyer or compliance professional

The registration application and the security requirements benefit from institutional compliance expertise, and a researcher new to Schedule I research should work with the institution’s compliance office rather than filing alone. Counsel can help where the protocol or the substance is unusual, where the DEA raises questions about the application, or where the institutional arrangements for holding the registration need to be structured. Starting the process early, with the right support, is the step that most often keeps a study on schedule.

You might also want to read

This article provides general legal information, not legal advice, and does not create an attorney-client relationship. Psychedelic law differs by state and changes over time. Consult a licensed attorney in your jurisdiction before acting on anything described here.